Illumina

Senior Informatics Sales Specialist - South

North Carolina, United States

Apply now

$60,000 – $90,000Compensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Medical Devices, Healthcare, Sales, Life SciencesIndustries

Requirements

Candidates should possess a Bachelor’s degree in a related field, with a minimum of 7 years of experience in informatics sales, specifically within the clinical or genomics space. Strong sales acumen and a deep understanding of the Illumina product portfolio are essential, along with demonstrated success in managing regional accounts and exceeding sales targets.

Responsibilities

The Senior Informatics Sales Specialist will be responsible for managing all aspects of business for assigned Regional Clinical Accounts, providing clinical support to account managers, developing strategic business plans to grow revenue, identifying and managing sales opportunities, preparing and presenting customer sales presentations, negotiating sales contracts, maintaining customer accounts within the CRM database, leveraging the CRM system to grow sales, providing sales forecasts, creating territory business plans, fulfilling product training requirements, and collaborating with TAM counterparts to support their selling efforts.

Skills

Sales

Clinical Sales

Genomics

Account Management

CRM

Territory Planning

Sales Forecasting

Product Presentation

Negotiation

Illumina

Supports genomics startups through funding and resources

About Illumina

Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.

Key Metrics

San Diego, CaliforniaHeadquarters

1998Year Founded

$27.2MTotal Funding

IPOCompany Stage

Venture Capital, BiotechnologyIndustries

5,001-10,000Employees

Risks

Over-reliance on NVIDIA's AI technology may limit flexibility in AI solution adoption.

Standardizing proteomics data across platforms could challenge Illumina's data reliability.

Single-flow-cell NovaSeq X System might cannibalize sales of higher-end models.

Differentiation

Illumina leads in genomic sequencing with advanced AI integration and multiomic data analysis.

The company offers innovative array-based solutions for DNA, RNA, and protein analysis.

Illumina's global expansion includes a new Global Capability Center in Bengaluru.

Upsides

Collaboration with NVIDIA enhances drug discovery and clinical development through AI integration.

Pilot proteomics program with UK Biobank aims to generate crucial reference datasets.

Single-cell sequencing kits make high-throughput sequencing accessible to smaller labs.

Land your dream remote job 3x faster with AI

Try Jobo Free